Request a Quote


researcher in the lab

With iSpecimen support, researchers drive growing market for regenerative medicine

December 18, 2020

Harvard scientists reported earlier this month that they essentially cured blindness in lab mice by delivering youth-restoring genes into the animals’ retinas, thus “turning back the clock” on their cells. The achievement perfectly parallels the breakthroughs medical researchers are pursuing for humans in the field of regenerative medicine – the repair, rejuvenation and replacement of diseased or damaged tissues and organs.

Read More

Person wearing mask for COVID-19

COVID-19 immunity shows signs of endurance

December 1, 2020

Some good news to be grateful for: New evidence suggests that COVID-19 immunity could last a long time after infection or vaccination – months, years, maybe even decades. That’s a good sign for the  vaccination programs expected to commence in coming months.

Read More

Person with mask

Lung fluid samples contribute to story of COVID-19

November 12, 2020

Supercomputing analysis of cellular gene expression data from COVID-19 patients’ lung fluid samples suggests potential new paths of investigation into treating the disease.

Read More

Researchers discover new biomarkers for stroke

October 29, 2020

Many strokes are missed when a clinician first examines the patient. That’s often because the classic stroke symptoms – drooping face, numbness in the arm, slurred speech – aren’t as obvious as they are in the most severely presenting cases. Despite less-obvious symptoms, these events can still lead to disability and death. Confirming a stroke […]

Read More

Urgent simultaneous requests for COVID-19 and ovarian cancer specimens

October 21, 2020

If you’re a client or regular reader, you know we’re committed to advancing the precision medicine revolution – the use of massive amounts of patient data to extract new insights about individuals, treatments and prognosis.

Read More

Sleeping man COVID patient

Older research could bring new insights for COVID-19 long haulers

October 6, 2020

Understanding the mechanisms behind the development of mono and CFS may well shed light on comparable mechanisms related to developing COVID-19 and “long COVID,” a condition characterized by CFS-like symptoms (problems with energy, memory and concentration) that endure  for weeks and months after the acute COVID-19 infection phase.

Read More

Woman ovarian cancer patient

Big volumes of specimen data help improve ovarian cancer prognosis

September 24, 2020

Human biospecimens contain massive volumes of potential data that can help researchers glean surprising new insights. That’s the case for an international team of researchers who have discovered that genetic signatures in ovarian cancer tissue can predict the patient’s survival more accurately than the combination of patient age and cancer stage.

Read More

The public health pro’s best friend

September 14, 2020

Labs and other canine friends can distinguish urine from a patient who has tested positive from cans of urine from noninfected patients, according to the Washington Post. Faced with an array of controls in the lab, they will even walk right by cake batter.

Read More

‘ALS on a Chip’ to Potentially Improve Personalized Medicine

August 27, 2020

A University of Central Florida research lab has developed “human-on-a-chip” technology that can be used to help assess the potential of new personalized therapy candidates for ALS.

Read More

Researcher holding a human biofluid sample

COVID-19 updates: Vaccine development, obesity worries, and plasma therapy

August 18, 2020

There’s a lot of news on COVID-19 (as always). First, some very good news: Vaccine development is progressing at a surprisingly brisk pace, with researchers arriving at phase 3 trials in six months, instead of years, raising the possibility of an approved vaccine faster than ever.

Read More

Previous   |   Next